{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:46:41Z","timestamp":1787014001905,"version":"build-2736575974"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"2018 Hebei key research and development programme health care and biomedicine special project","award":["18277713D"],"award-info":[{"award-number":["18277713D"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in reproductive\u2010age women. Irisin is considered to play a role in metabolic disorder and\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      . However, correlation between irisin and metabolic disorder in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      is not clear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>\n                      This is a prospective study. Forty patients with\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      and thirty patients without\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      were recruited for in vitro fertilization and embryo transfer (\n                      <jats:styled-content style=\"fixed-case\">IVF<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">ET<\/jats:styled-content>\n                      ). All\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      women fulfilled all three Rotterdam consensus criteria. In each group, patients were also divided into obese and nonobese patients, and patients with or without dyslipidaemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum irisin level in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      patients was significantly reduced. Irisin level in obese\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      patients was significantly lower than in nonobese\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      patients. Irisin level in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      patients with dyslipidaemia was significantly higher than in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      patients with normal blood lipid profile. In both\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      and control patients, serum irisin level was negatively correlated with body weight and waist\u2010hip ratio (\n                      <jats:styled-content style=\"fixed-case\">WHR<\/jats:styled-content>\n                      ). Moreover, serum irisin level was positively correlated with body fat rate,\n                      <jats:styled-content style=\"fixed-case\">BAI<\/jats:styled-content>\n                      , fasting plasma glucose (\n                      <jats:styled-content style=\"fixed-case\">FPG<\/jats:styled-content>\n                      ) and\n                      <jats:styled-content style=\"fixed-case\">HOMA<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IR<\/jats:styled-content>\n                      in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      patients. In addition, serum irisin level was positively correlated with\n                      <jats:styled-content style=\"fixed-case\">HOMA<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IR<\/jats:styled-content>\n                      in control patients. In\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      patients, body weight and\n                      <jats:styled-content style=\"fixed-case\">HOMA<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IR<\/jats:styled-content>\n                      could predict the level of irisin. In control patients, body mass index (\n                      <jats:styled-content style=\"fixed-case\">BMI<\/jats:styled-content>\n                      ) could predict the level of irisin. Expression of irisin in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      patients was lower than that in control patients. However, there was no significant difference of irisin expression between the subdivided groups in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      and control patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Taken together, the present findings enriched the knowledge about the role of irisin in metabolic dysfunction in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cen.13805","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T14:33:41Z","timestamp":1530714821000},"page":"474-480","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients"],"prefix":"10.1111","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-7301","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Reproduction The Second Hospital of Hebei Medical University  Shijiazhuang Hebei China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center Xingtai Infertility Specialist Hospital  Xingtai Hebei China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Reproduction Shijiazhuang Obstetrics and Gynecology Hospital  Shijiazhuang Hebei China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Reproduction The Second Hospital of Hebei Medical University  Shijiazhuang Hebei China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2013.829445"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(01)00640-2"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.1.165"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2724"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2013.56.3.137"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2013.04.016"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2674"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1658"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S37559"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10777"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1180"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2012.09.002"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2544"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1290"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2009.11.010"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1495-0"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2749"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094235"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajhb.22493"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2373"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2012.11.014"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2013.03.002"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.01.007"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2014.7"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0076"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.13805","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.13805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T22:10:11Z","timestamp":1694988611000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.13805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/cen.13805"],"URL":"https:\/\/doi.org\/10.1111\/cen.13805","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"assertion":[{"value":"2018-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}